EAM Investors, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 156 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2018$4,751,000
+16.1%
65,683
+5.6%
0.79%
+7.9%
Q4 2017$4,093,000
-12.1%
62,172
-33.1%
0.73%
+18.4%
Q3 2017$4,656,000
+0.4%
92,899
-7.3%
0.62%
-19.2%
Q2 2017$4,636,000
+2.3%
100,170
-21.9%
0.77%
+7.3%
Q1 2017$4,530,000
-45.2%
128,300
+43.6%
0.71%
-25.2%
Q1 2015$8,272,000
+11.2%
89,335
-51.5%
0.96%
-8.0%
Q4 2014$7,442,000
+341.4%
184,020
+167.0%
1.04%
+202.6%
Q3 2014$1,686,00068,9210.34%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2015
NameSharesValueWeighting ↓
Meditor Group Ltd 3,791,300$3,715,4744.82%
Two Seas Capital LP 7,672,170$7,518,7271.51%
Parkman Healthcare Partners LLC 1,997,071$1,957,1300.36%
Monaco Asset Management SAM 1,171,779$1,148,3430.34%
TANG CAPITAL MANAGEMENT LLC 1,850,000$1,813,0000.26%
Ikarian Capital, LLC 1,737,636$1,702,8830.20%
PLATINUM INVESTMENT MANAGEMENT LTD 3,189,517$3,125,7270.12%
GSA CAPITAL PARTNERS LLP 1,116,655$1,0940.09%
XTX Topco Ltd 519,129$508,7460.09%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 60,000$58,8000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders